EDGAR Filing Documents for 0000357097-17-000028

Form 8-K - Current report:

SEC Accession No. 0000357097-17-000028

Filing Date

2017-03-08

Accepted

2017-03-08 17:15:41

Documents

Period of Report

2017-03-07

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	fcsc030717form8-k.htm	8-K	54003
2	EXHIBIT 3.1	exhibit31seriesaps030817.htm	EX-3.1	108822
3	EXHIBIT 4.1	exhibit41formofwarrant0308.htm	EX-4.1	132545
4	EXHIBIT 5.1	exhibit51legalopinion030817.htm	EX-5.1	15505
5	EXHIBIT 10.1	exhibit101purchaseagreemen.htm	EX-10.1	163076
6	EXHIBIT 12.1	exhibit121ratiooffixedchar.htm	EX-12.1	58853
7	EXHIBIT 99.1	exhibit991updatedriskfacto.htm	EX-99.1	312005
8	EXHIBIT 99.2	exhibit992pressrelease0307.htm	EX-99.2	12422
9		fcsclogocolor.jpg	GRAPHIC	74382
10		hoganlogo2017.jpg	GRAPHIC	8798
	Complete submission text file	0000357097-17-000028.txt		971090

Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341

Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000

Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)